Literature DB >> 33016684

Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes.

Janusz Marcinkiewicz, Henryk Mazurek, Grzegorz Majka, Benjamin Chain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33016684     DOI： 10.20452/pamw.15630

Source DB:  PubMed          Journal:  Pol Arch Intern Med        ISSN： 0032-3772


× No keyword cloud information.
  2 in total

1.  Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.

Authors:  Grzegorz Majka; Henryk Mazurek; Magdalena Strus; Marta Ciszek-Lenda; Rafał Szatanek; Agnieszka Pac; Edyta Golińska; Janusz Marcinkiewicz
Journal:  Clin Exp Immunol       Date:  2021-06-16       Impact factor: 5.732

2.  Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic.

Authors:  Hannah R Mathew; May Y Choi; Michael D Parkins; Marvin J Fritzler
Journal:  BMC Pulm Med       Date:  2021-05-20       Impact factor: 3.317
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.